Pacific Biosciences of California, Inc.
€1.113
EUR
Last updated on --.
24h volume3.47M
24h highest1.1266 EUR
24h lowest1.0750 EUR
24h Price movement+2.78%
PACB recent prices
24 Hours
+2.78%+€0.0301
30 days
-19.30%-€0.2623
60 days
+1.19%+€0.0129
90 days
-24.11%-€0.3483
Key data
Previous close1.0836 EUR
Market cap317.87M EUR
Volume3.47M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.35260 EUR
Net income (FY)-110.58M EUR
Revenue (FY)137.63M EUR
Last report date8 May 2026
About Pacific Biosciences of California, Inc.
HeadquartersMENLO PARK
Employees (FY)485.00
Revenue per employee (FY)283.76K EUR
Net income per employee (FY)-227.99K EUR
Listed onNasdaq
PACB conversion tables
 |  |
|---|---|
| 0.5 PACB | 0.55685 EUR |
| 1 PACB | 1.113 EUR |
| 5 PACB | 5.568 EUR |
| 10 PACB | 11.13 EUR |
| |
|---|---|
| 0.5 EUR | 0.44895 PACB |
| 1 EUR | 0.89791 PACB |
| 5 EUR | 4.489 PACB |
| 10 EUR | 8.979 PACB |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PACB is trading at €1.113, +2.78% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PACB stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PACB is currently trading at €1.113, +2.78% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PACB price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the LABORATORY ANALYTICAL INSTRUMENTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PACB's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PACB; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PACB's historical range and other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector.
Pacific Biosciences of California, Inc.'s market cap is currently 317.87M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.47M
24h highest1.1266 EUR
24h lowest1.0750 EUR
24h Price movement+2.78%
Start trade with PACB Perpetual
Sign up to trade